AIM ImmunoTech Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
AIM ImmunoTech Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • AIM ImmunoTech Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.49M, a 45% increase year-over-year.
  • AIM ImmunoTech Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$27.9M, a 19% decline year-over-year.
  • AIM ImmunoTech Inc. annual Operating Income (Loss) for 2023 was -$31.9M, a 60.2% decline from 2022.
  • AIM ImmunoTech Inc. annual Operating Income (Loss) for 2022 was -$19.9M, a 5.76% decline from 2021.
  • AIM ImmunoTech Inc. annual Operating Income (Loss) for 2021 was -$18.8M, a 24.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$27.9M -$4.49M +$3.67M +45% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$31.6M -$3.69M +$1.77M +32.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$33.4M -$5.73M -$1.44M -33.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$31.9M -$14M -$8.45M -152% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$23.5M -$8.16M -$1.64M -25.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$21.8M -$5.46M -$766K -16.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$21.1M -$4.3M -$1.14M -36.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$19.9M -$5.56M +$1.89M +25.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$21.8M -$6.52M -$2.59M -66% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$19.2M -$4.7M -$977K -26.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$18.2M -$3.15M +$593K +15.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$18.8M -$7.45M -$2.31M -45.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$16.5M -$3.93M -$574K -17.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$16M -$3.72M -$378K -11.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$15.6M -$3.75M -$420K -12.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$15.2M -$5.13M -$2.04M -66.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$13.1M -$3.36M -$150K -4.68% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$13M -$3.34M -$116K -3.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$12.8M -$3.33M -$399K -13.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$12.4M -$3.09M -$427K -16% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$12M -$3.21M -$167K -5.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$11.8M -$3.22M +$3K +0.09% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$11.9M -$2.93M -$356K -13.9% Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-05-14
Q4 2018 -$11.5M -$2.66M +$132K +4.73% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$11.6M -$3.04M -$386K -14.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$11.2M -$3.23M -$497K -18.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$10.7M -$2.57M +$671K +20.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$11.4M -$2.79M +$1.29M +31.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$12.7M -$2.65M +$574K +17.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$13.3M -$2.73M +$84K +2.99% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$13.4M -$3.24M +$438K +11.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$13.8M -$4.09M -$1.24M -43.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 -$12.6M -$3.23M +$757K +19% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$13.3M -$2.81M +$2.09M +42.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$15.4M -$3.68M +$1.24M +25.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$16.7M -$2.84M +$1.73M +37.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-30
Q3 2015 -$18.4M -$3.98M +$346K +7.99% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$18.7M -$4.9M +$184K +3.62% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$18.9M -$4.92M +$189K +3.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$19.1M -$4.57M -$1.16M -34% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-31
Q3 2014 -$17.9M -$4.33M +$130K +2.92% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$18.1M -$5.09M -$351K -7.41% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$17.7M -$5.11M -$550K -12.1% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$17.2M -$3.41M +$4.58M +57.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-29
Q3 2013 -$21.8M -$4.46M +$506K +10.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$22.3M -$4.73M -$1.1M -30.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$21.2M -$4.56M -$815K -21.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$20.3M -$8M -$4.1M -105% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-19
Q3 2012 -$16.2M -$4.97M -$1.41M -39.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 -$14.8M -$3.63M -$385K -11.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$14.5M -$3.75M -$157K -4.37% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 -$14.3M -$3.9M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-14
Q3 2011 -$3.56M +$135K +3.66% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 -$3.25M +$521K +13.8% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 -$3.59M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
Q3 2010 -$3.69M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 -$3.77M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.